Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 2 | $18,475,760 |
Sells | 60 | $26,508,863 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 May 2024 17:30 | VERV | Verve Therapeutics Inc | ASHE ANDREW D. | See Remarks | 14 May 2024 | Purchase | 76,000 | 6.26 | 475,760 | D |
03 Apr 2024 17:00 | VERV | Verve Therapeutics Inc | NICKERSON JOAN | Chief Administrative Officer | 02 Apr 2024 | Sale | 1,514 | 8.24 | 12,475 | D |
05 Dec 2023 16:30 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 01 Dec 2023 | Purchase | 1,800,000 | 10 | 18,000,000 | I |
01 Dec 2023 16:30 | VERV | Verve Therapeutics Inc | DORVAL ALLISON | Chief Financial Officer | 29 Nov 2023 | Sale | 554 | 11.45 | 6,343 | D |
02 Dec 2022 17:00 | VERV | Verve Therapeutics Inc | BELLINGER ANDREW | CSO & CMO | 01 Dec 2022 | Sale | 865 | 22.95 | 19,852 | D |
01 Dec 2022 17:00 | VERV | Verve Therapeutics Inc | DORVAL ALLISON | Chief Financial Officer | 29 Nov 2022 | Sale | 554 | 22.1 | 12,243 | D |
08 Nov 2022 17:51 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 04 Nov 2022 | Sale | 243 | 32.9 | 7,995 | I |
08 Nov 2022 17:51 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 04 Nov 2022 | Sale | 650 | 31.9905 | 20,794 | I |
08 Nov 2022 17:51 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 04 Nov 2022 | Sale | 47,690 | 31.118 | 1,484,017 | I |
08 Nov 2022 17:04 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 04 Nov 2022 | Sale | 243 | 32.9 | 7,995 | I |
08 Nov 2022 17:04 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 04 Nov 2022 | Sale | 650 | 31.9905 | 20,794 | I |
08 Nov 2022 17:04 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 04 Nov 2022 | Sale | 47,690 | 31.118 | 1,484,017 | I |
08 Nov 2022 17:04 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 04 Nov 2022 | Sale | 242 | 32.9 | 7,962 | I |
08 Nov 2022 17:04 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 04 Nov 2022 | Sale | 651 | 31.9905 | 20,826 | I |
08 Nov 2022 17:04 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 04 Nov 2022 | Sale | 47,690 | 31.118 | 1,484,017 | I |
04 Nov 2022 17:58 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 03 Nov 2022 | Sale | 1,755 | 33.8373 | 59,384 | I |
04 Nov 2022 17:58 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 03 Nov 2022 | Sale | 25,534 | 33.1384 | 846,156 | I |
04 Nov 2022 17:58 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 03 Nov 2022 | Sale | 22,279 | 32.3155 | 719,957 | I |
04 Nov 2022 17:58 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 02 Nov 2022 | Sale | 8,930 | 36.775 | 328,401 | I |
04 Nov 2022 17:58 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 02 Nov 2022 | Sale | 10,372 | 36.2786 | 376,282 | I |
04 Nov 2022 17:58 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 02 Nov 2022 | Sale | 9,350 | 34.7754 | 325,150 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 03 Nov 2022 | Sale | 1,755 | 33.8373 | 59,384 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 03 Nov 2022 | Sale | 25,534 | 33.1384 | 846,156 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 03 Nov 2022 | Sale | 22,279 | 32.3155 | 719,957 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 03 Nov 2022 | Sale | 1,755 | 33.8373 | 59,384 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 03 Nov 2022 | Sale | 25,535 | 33.1384 | 846,189 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 03 Nov 2022 | Sale | 22,279 | 32.3155 | 719,957 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 02 Nov 2022 | Sale | 8,930 | 36.775 | 328,401 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 02 Nov 2022 | Sale | 10,372 | 36.2786 | 376,282 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 02 Nov 2022 | Sale | 9,350 | 34.7754 | 325,150 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 02 Nov 2022 | Sale | 8,930 | 36.775 | 328,401 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 02 Nov 2022 | Sale | 10,372 | 36.2786 | 376,282 | I |
04 Nov 2022 16:16 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 02 Nov 2022 | Sale | 9,349 | 34.7754 | 325,115 | I |
02 Nov 2022 21:02 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 01 Nov 2022 | Sale | 260 | 38.6385 | 10,046 | I |
02 Nov 2022 21:02 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 01 Nov 2022 | Sale | 2,377 | 37.821 | 89,901 | I |
02 Nov 2022 21:02 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 01 Nov 2022 | Sale | 29,326 | 36.6878 | 1,075,906 | I |
02 Nov 2022 21:02 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 31 Oct 2022 | Sale | 88 | 40.6445 | 3,577 | I |
02 Nov 2022 21:02 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 31 Oct 2022 | Sale | 6,601 | 40.1569 | 265,076 | I |
02 Nov 2022 21:02 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 31 Oct 2022 | Sale | 23,275 | 38.9432 | 906,403 | I |
02 Nov 2022 21:02 | VERV | Verve Therapeutics Inc | YESHWANT KRISHNA | Director , 10% | 31 Oct 2022 | Sale | 23,732 | 37.9061 | 899,588 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 01 Nov 2022 | Sale | 260 | 38.6385 | 10,046 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 01 Nov 2022 | Sale | 2,377 | 37.821 | 89,901 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 01 Nov 2022 | Sale | 29,326 | 36.6878 | 1,075,906 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 01 Nov 2022 | Sale | 260 | 38.6385 | 10,046 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 01 Nov 2022 | Sale | 2,377 | 37.821 | 89,901 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 01 Nov 2022 | Sale | 29,326 | 36.6878 | 1,075,906 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 31 Oct 2022 | Sale | 88 | 40.6445 | 3,577 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 31 Oct 2022 | Sale | 6,601 | 40.1569 | 265,076 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 31 Oct 2022 | Sale | 23,275 | 38.9432 | 906,403 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 31 Oct 2022 | Sale | 23,732 | 37.9061 | 899,588 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 31 Oct 2022 | Sale | 88 | 40.6445 | 3,577 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 31 Oct 2022 | Sale | 6,601 | 40.1569 | 265,076 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 31 Oct 2022 | Sale | 23,276 | 38.9432 | 906,442 | I |
02 Nov 2022 16:25 | VERV | Verve Therapeutics Inc | GV 2017 GP, L.L.C. | Member of 10% Group | 31 Oct 2022 | Sale | 23,732 | 37.9061 | 899,588 | I |
01 Nov 2022 17:00 | VERV | Verve Therapeutics Inc | BELLINGER ANDREW | CSO & CMO | 28 Oct 2022 | Sale | 10,000 | 39.9 | 399,000 | D |
05 Oct 2022 17:00 | VERV | Verve Therapeutics Inc | KATHIRESAN SEKAR | Chief Executive Officer | 03 Oct 2022 | Sale | 9,904 | 34.9723 | 346,366 | D |
05 Oct 2022 17:00 | VERV | Verve Therapeutics Inc | KATHIRESAN SEKAR | Chief Executive Officer | 03 Oct 2022 | Sale | 11,185 | 34.1296 | 381,740 | D |
05 Oct 2022 17:00 | VERV | Verve Therapeutics Inc | KATHIRESAN SEKAR | Chief Executive Officer | 03 Oct 2022 | Sale | 28,911 | 33.0157 | 954,517 | D |
27 Sep 2022 17:00 | VERV | Verve Therapeutics Inc | BELLINGER ANDREW | CSO & CMO | 23 Sep 2022 | Sale | 3,202 | 36.0336 | 115,380 | D |
27 Sep 2022 17:00 | VERV | Verve Therapeutics Inc | BELLINGER ANDREW | CSO & CMO | 23 Sep 2022 | Sale | 36,798 | 35.3091 | 1,299,304 | D |
27 Sep 2022 17:00 | VERV | Verve Therapeutics Inc | BELLINGER ANDREW | CSO & CMO | 23 Sep 2022 | Sale | 13,368 | 35.5927 | 475,803 | D |
27 Sep 2022 17:00 | VERV | Verve Therapeutics Inc | BELLINGER ANDREW | CSO & CMO | 23 Sep 2022 | Sale | 6,632 | 34.666 | 229,905 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)